Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026)
Neuronetics' (STIM) quarterly Depreciation & Amortization (CF) came in at $745000.0 in Q1 2026, down 18.22% year-on-year from $911000.0 in Q1 2025, and down 2.87% on a QoQ basis from $767000.0 in Q4 2025.
Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $745000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 18.22% year-over-year to $745000.0 in Q1 2026; TTM through Mar 2026 was $3.3 million, a 36.1% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 67.15% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $745000.0, down from $767000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for STIM reached as high as $911000.0 in Q1 2025 and fell as low as $319000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $584529.4 across 5 years, with a median of $516000.0 in 2023.
- Across the five-year window, Depreciation & Amortization (CF) jumped 106.85% in 2022 and dropped 18.22% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $604000.0 in 2022, then retreated by 16.72% to $503000.0 in 2023, then dropped by 11.33% to $446000.0 in 2024, then soared by 71.97% to $767000.0 in 2025, then declined by 2.87% to $745000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $745000.0 in Q1 2026, $767000.0 in Q4 2025, and $886000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 745,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 745,000.00 |
| Mar 31, 2026 | 745,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Jun 30, 2025 | 901,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Mar 31, 2025 | 911,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Sep 30, 2024 | 512,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Jun 30, 2024 | 555,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Dec 31, 2023 | 503,000.00 |
| Dec 31, 2023 | 503,000.00 |